FIELD: medicine. SUBSTANCE: method involves administering first perifoveal and then panretinal retina coagulation. Treatment is administered when glycemia level corresponding to Hb A1 12-15% in 4-5 treatments long courses to be repeated every 1-1.5 months. Corticosteroid tablets are administered in parallel with laser coagulation treatment. EFFECT: maximum retained vision function. 2 cl, 2 dwg, 9 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF DIABETIC RETINOPATHY PROGRESSION IN PREGNANT WOMEN WITH DIABETES MELLITUS | 2023 |
|
RU2814772C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF TRANSIENT AND DIABETIC RETINOPATHY IN PREGNANT WOMEN WITH TYPE 1 DIABETES MELLITUS | 2021 |
|
RU2805589C2 |
| METHOD OF CONSERVATIVE TREATMENT OF RECURRENT HAEMOPHTHALMIA IN DIABETIC RETINOPATHY | 2012 |
|
RU2485944C1 |
| METHOD FOR PREDICTING THE RISK OF PROGRESSION OF DIABETIC RETINOPATHY IN PREGNANT WOMEN WITH DIABETES MELLITUS | 2023 |
|
RU2809639C1 |
| METHOD OF TREATING PAPILLARY AND PAPILLOVITREAL NEOVASCULARISATION IN CASE OF PROLIFERATIVE DIABETIC RETINOPATHY | 2009 |
|
RU2395260C1 |
| METHOD OF WIDE - SPREAD HEMOPHTHALMIA AND TOTAL HEMOPHTHALMIA TREATMENT IN PATIENTS WITH DIABETIC RETINOPATHY | 2008 |
|
RU2391954C2 |
| METHOD OF TREATMENT OF PATIENTS WITH DIABETIC RETINOPATHY | 1996 |
|
RU2124337C1 |
| METHOD FOR PREDICTION OF HIGH RISK OF DEVELOPING PROLIFERATIVE DIABETIC RETINOPATHY IN PREGNANT WOMEN WITH TYPE 1 DIABETES MELLITUS | 2019 |
|
RU2710498C1 |
| METHOD OF SURGICAL TREATMENT OF PATIENTS WITH PROLIFERATIVE VITRECTONOMY WITH SYNECHIAE REMOVAL AGAINST THE BACKGROUND OF DIABETES MELLITUS | 2017 |
|
RU2675463C1 |
| METHOD FOR EARLY DIAGNOSIS AND PREDICTION OF MACULAR EDEMA IN DIABETIC RETINOPATHY | 2020 |
|
RU2741693C1 |
